Production of anti-idiotype antibody against human monoclonal sperm immobilization antibody
抗人单克隆精子固定化抗体抗独特型抗体的制备
基本信息
- 批准号:01571238
- 负责人:
- 金额:$ 1.22万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1989
- 资助国家:日本
- 起止时间:1989 至 1990
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Anti-idiotipic antibodies in mice against human monoclonal sperm immobilization antibody (H6-3C4) were produced to analyze the possibility for contraceptive vaccine by using anti-idiotype antibodies for internal image of antigen of sperm immobilization in animals and human. Sera from mice immunized with H6-3C4 were absorbed with human gamma globulin and purified antisera (AB2) were confirmed to react the H6-3C4. AB2 neutralized both sperm immobilizing activity of H6-3C4 and En46-A4 to human sperm. AS En46-A4 is class switched human SI-ab (IgGl) from H6-3C4 (IgM) by recombinant DNA technology, both antibodies were used same V gene for immunoglobulin. Then these have same antigen binding specificity (paratope) on the differrent class of immunoglobulin.Sera from rats and rabbit immunized with AB2 showed significant human sperm immobilization activity. These data suggested that AB2 contained internal image of sperm immobilizing antigen for rat and rabbit and could be suitable candidate for contraceptive vaccine instead of purified sperm antigen in animals and human.Then, we produced murine monoclonal anti-idiotype antibody against Mab H6-3C4 (Mono AB2) in order to apply for human. Four Mono AB2s were specific for H6-3C4 and one Mono AB2 had neutrizing activity of sperm immobilizing activity of H6-3C4.Rat antiserum against Mono AB2 had no sperm immobilizing activity for human sperm. Now we were making another murine Mono AB2.
用抗人精子固定化单克隆抗体(H6- 3C 4)制备小鼠抗独特型抗体,分析其对动物和人精子固定化抗原的内成像,作为避孕疫苗的可能性。用人γ球蛋白吸收来自用H6- 3C 4免疫的小鼠的血清,并证实纯化的抗血清(AB 2)与H6- 3C 4反应。AB 2中和H6- 3C 4和En 46-A4对人精子的精子固定活性。由于En 46-A4是通过重组DNA技术从H6- 3C 4(IgM)进行类别转换的人SI-ab(IgGl),两种抗体使用相同的免疫球蛋白V基因。AB_2免疫的大鼠和家兔血清均显示出明显的人精子固定活性。本研究制备了鼠抗单克隆抗体H6- 3C 4(Mono AB 2),并将其应用于人。4株Mono AB 2对H6- 3C 4有特异性,1株Mono AB 2对H6- 3C 4有中和精子的活性,而抗Mono AB 2的大鼠抗血清对人精子无固定活性。现在我们正在制造另一种鼠单核细胞AB 2。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
M.Shigeta,K.Sakata,S.Isojima: "Production and characterization of anfi-idiotypic antibody (AB2) against human monodonal sperm immobilzation antibody H6-3C4 (AB1)" Proceeding of the 5th Annual Meeting of Japan Society for Basic Reproductive Immunology and
M.Shigeta、K.Sakata、S.Isojima:“针对人单克隆精子固定化抗体 H6-3C4 (AB1) 的抗独特型抗体 (AB2) 的生产和表征”日本基础生殖免疫学会第五届年会论文集
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
M.SHIGETA: "Idiotype Cross-reactivity of Sperm immobilizing antibodies in infertile patient sera,which was difined with monodonal antibodies" Journal of Reproductive Immunology. Supplement. 48 (1989)
M.SHIGETA:“不育患者血清中精子固定抗体的独特型交叉反应性,用单克隆抗体确定”《生殖免疫学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
M. SHIGETA ; K. SAKATA ; S. ISOJIMA: "Production and characterization of anti-idiotypic antibody (AB2) against human monodoual sperm immobilization amtibody H6-3 C4 (AB1)" Proceedings of the 5th Annual Meeting of Japan society for Basic Reproductive immun
重田先生;
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHIGETA Minoru其他文献
SHIGETA Minoru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHIGETA Minoru', 18)}}的其他基金
Research for T epitope of a zona pellucida and application for vaccine
透明带T表位的研究及疫苗应用
- 批准号:
08660353 - 财政年份:1996
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
新生期接种乙肝疫苗(hepatitis B vaccine,HBV)影响小鼠情绪相关行为及其机制研究
- 批准号:31600836
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of a Cell-Based Assay for Tetanus Vaccine Quality Control
破伤风疫苗质量控制细胞检测方法的开发
- 批准号:
10101986 - 财政年份:2024
- 资助金额:
$ 1.22万 - 项目类别:
Collaborative R&D
Developing an infection-blocking pan-coronavirus vaccine
开发阻断感染的泛冠状病毒疫苗
- 批准号:
MR/Y019466/1 - 财政年份:2024
- 资助金额:
$ 1.22万 - 项目类别:
Research Grant
Vaccine hesitancy DAISI (Digital Animation in Service Improvement): To increase vaccine uptake in ethnic minority perinatal women and young children.
疫苗犹豫 DAISI(服务改进中的数字动画):提高少数民族围产期妇女和幼儿的疫苗接种率。
- 批准号:
MR/Z503964/1 - 财政年份:2024
- 资助金额:
$ 1.22万 - 项目类别:
Research Grant
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 1.22万 - 项目类别:
Research Grant
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 1.22万 - 项目类别:
Standard Grant
Evolutionarily smart vaccine strain selection for proactive vaccinology
用于主动疫苗学的进化智能疫苗株选择
- 批准号:
MR/Y004337/1 - 财政年份:2024
- 资助金额:
$ 1.22万 - 项目类别:
Research Grant
Development of a mucosally-delivered and active salmon louse vaccine for Atlantic salmon aquaculture
开发用于大西洋鲑鱼水产养殖的粘膜递送活性鲑鱼虱疫苗
- 批准号:
BB/Y006534/1 - 财政年份:2024
- 资助金额:
$ 1.22万 - 项目类别:
Research Grant
Application of the virus-like particle (VLP) technology in the development of anti-tick vaccine, utilizing novel salivary proteins from Haemaphysalis longicornis ticks.
利用长角血蜱的新型唾液蛋白,应用病毒样颗粒(VLP)技术开发抗蜱疫苗。
- 批准号:
24K18027 - 财政年份:2024
- 资助金额:
$ 1.22万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A novel self-adjuvanting vaccine platform
一种新型的自我辅助疫苗平台
- 批准号:
MR/Z503885/1 - 财政年份:2024
- 资助金额:
$ 1.22万 - 项目类别:
Research Grant
Characterize the HCV vaccine-induced humoral response
表征 HCV 疫苗诱导的体液反应
- 批准号:
502574 - 财政年份:2024
- 资助金额:
$ 1.22万 - 项目类别: